Senior Director, Health Economics and Outcomes Research, International

BridgeBio
Switzerland
Workplace: OnsiteFull timeFunction: Research & Scientific (R&D)Education: phdSkills: ["Collaboration","Communication","Adaptability","Project management","Stakeholder management"]

Lead the international HEOR strategy to generate health economics and outcomes research evidence that secures timely, sustainable patient access. Oversee HTA submissions, value dossiers, and real-world evidence studies across multiple markets, aligning HEOR priorities with clinical value, launch timelines, and market access strategy. Partner with Market Access, Medical Affairs, Commercial, and Launch Excellence stakeholders, manage vendors and non-interventional studies, and engage HTA/payer bodies to support reimbursement dossiers.

Loading

Loading job details...

Preparing the role view and application actions.

FursaFursa
BridgeBio
BridgeBio
1 month ago

Senior Director, Health Economics and Outcomes Research, International

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI
Last checked: 6 hours agoStatus: Live

Job Summary

Lead the international HEOR strategy to generate health economics and outcomes research evidence that secures timely, sustainable patient access. Oversee HTA submissions, value dossiers, and real-world evidence studies across multiple markets, aligning HEOR priorities with clinical value, launch timelines, and market access strategy. Partner with Market Access, Medical Affairs, Commercial, and Launch Excellence stakeholders, manage vendors and non-interventional studies, and engage HTA/payer bodies to support reimbursement dossiers.
Location: Switzerland
Workplace: Onsite
Employment Type: Full time
Job Function: Research & Scientific (R&D)
Seniority: Sr. Director level

Key Responsibilities

  • •Define and lead the international HEOR strategy to align with market access and launch objectives across therapeutic areas.
  • •Design and oversee non-interventional studies, including registries and real-world evidence generation, from protocol development through publication.
  • •Lead early payer engagement with key HTA/payer bodies to inform evidence generation strategy and reimbursement dossier development.
  • •Collaborate with Market Access, Medical Affairs, and Commercial colleagues to optimize value and access across international launches.
  • •Provide health economic modeling and outcomes research expertise to support pricing and reimbursement strategy; manage external vendors, budgets, and contracts for HEOR studies.
Travel: Low travel

Pay and Benefits

Equity and Bonus:Equity
Perks:401kEquityHealth InsuranceDentalVisionHsaFsaPaid LeaveParental LeaveAnnual BonusMeal Allowance

Key Requirements

  • •Graduate degree in health economics, epidemiology, health services research, or related public health field (PhD preferred), plus 9+ years of experience with an MSc/MPH or 7+ years with a PhD in HEOR or related fields.
  • •Extensive experience leading HTA submissions and pricing negotiations across multiple international markets, ideally including Europe, in rare diseases and orphan conditions.
  • •Direct experience engaging with HTA organizations such as NICE, CADTH, PBAC, HAS, IQWiG/G-BA, and ICER.
  • •In-depth understanding of health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies, including registries and observational study design, implementation, analysis, and interpretation.
  • •Ability to independently manage complex, multicultural, cross-functional teams and non-interventional study projects internationally.
Experience:BiopharmaHealth economicsOutcomes researchHEORHealthcareRare diseases
Education:PhD / Doctorate
Skills:CollaborationCommunicationAdaptabilityProject managementStakeholder management
Languages:English

Company Brief

BridgeBio
Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.
Industry: Biotech
Company Size: Large (251 to 1,000 employees)
Growth: Public Company
Valuation: Public Company (Market Cap in USD)
Funding: IPO / Publicly Listed
Headquarters: Palo Alto, United States
Founded: 2015
WebsiteLinkedIn